- PMID 23596418.
Gastaldon C, Sc****tsanitis G,
Arzenton E,
Raschi E,
Papola D,
Ostuzzi G,
Moretti U,
Seifritz E, Kane JM, Trifirò G,
Barbui C (December 2022)...
- PMID 25001071.
Bertolini F,
Robertson L,
Bisson JI,
Meader N,
Churchill R,
Ostuzzi G, et al. (10
February 2022).
Cochrane Common Mental Disorders Group (ed...
- 1193–212. doi:10.2147/TCRM.S55313. PMC 4542474. PMID 26316764.
Koesters M,
Ostuzzi G,
Guaiana G,
Breilmann J,
Barbui C (July 2017). "Vortioxetine for depression...
- Italy 10
Antonio De
Giovanni P Italy 12
Joshua Pascon S Italy 14 M****imo
Ostuzzi S Italy 15
Alberto Venturini S Italy 16
Sebastiano Santi L Italy...
-
Callovini T,
Riboldi I,
Crocamo C, D'Agostino A,
Martinotti G,
Bertolini F,
Ostuzzi G,
Barbui C, Carrà G (March 2022). "Comparing 1-year
effectiveness and...
- 7759/cureus.17352. PMC 8381465. PMID 34447651.
Gastaldon C,
Papola D,
Ostuzzi G,
Barbui C (December 2019). "Esketamine for
treatment resistant depression:...
-
terms of
product openness are
specified by the open
source definition.
Ostuzzi et al.
define open
design as a
product property, i.e. the
spaces of freedom...
- 1177/2045125313507739. PMC 3952483. PMID 24688759.
Gastaldon C,
Papola D,
Ostuzzi G,
Barbui C (December 2019). "Esketamine for
treatment resistant depression:...
